News

2021 Haval new cars

Confirmation ending, Haval has a wave of fresh metal under consideration for 2021
- shares

It was a case of steady as it goes for SUV brand, Haval, in 2020.

No new models arrived last year, though the very tail end of 2019 saw an update to the H2 small SUV filter into showrooms. H2 sales more than doubled during 2020, and the brand as a whole grew sales by almost 90 per cent over the year.

The pace is set to pick up in the new year.

Although confirmed details are still to follow, the Haval Concept H of 2020 looks like a strong indication of what to expect from a next-generation H2. The timing for replacement is right, however Haval hasn't locked anything in just yet.

The medium H6 SUV is also set to receive a redesign, switching to the Chinese-market H6 unveiled at the Beijing motor show during 2020. That's pure speculation for now though, with the brand still to confirm its future direction.

Also under consideration, though far from confirmed are two new models that would see the brand expand its portfolio.

The Haval Big Dog sticks to a familiar medium SUV format, with unibody construction and a choice of front- or all-wheel drive. The Big Dog steps in for the Haval H5 in China, which was last seen in Australia as the Great Wall X200 and X240, but uses a version of the new H6 chassis.

Higher up the range, the Tank 300 is also being investigated for local market suitability. Slightly larger than the Big Dog, the Tank 300 serves as a more rugged body-on-frame SUV with a choice of turbo petrol or turbo diesel engines, four-wheel drive, and multi-link live axle rear suspension.

Right now the Tank 300 sells overseas under Haval's more premium Wey brand, though it's unlikely the Great Wall Motors - Haval group would add yet another marque to its range, prompting an expected rebadge, if the Tank finds its way here.

ModelWhat's new?SegmentDue
H2New modelSmall SUVUnconfirmed
H6New modelMedium SUVUnconfirmed
Big DogNew modelMedium SUVUnconfirmed
Tank 300New modelMedium/Large SUVUnconfirmed